Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric oxygen therapy after cerebral infarction
2019-000740-10Phase 2Terminated
- Sponsor
- NUI
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxygen gas in brain infarction, sponsored by NUI. Primary endpoint: Safety and feasibility of hyperbaric oxygen therapy period. Started Nov 2019; status: terminated.
02
Drugs
oxygen gas
03
Conditions
brain infarction
Beyond the preview
Go deeper on 2019-000740-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000740-10.